19
Views
6
CrossRef citations to date
0
Altmetric
Original Article

MDR-1 Expression and Deletions of Chromosomes 7 and 5(Q) Separately Indicate Adverse Prognosis in AML

, , , , &
Pages 613-623 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Elizabeth Fox & Susan E Bates. (2007) Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor. Expert Review of Anticancer Therapy 7:4, pages 447-459.
Read now
Daniel Steinbach, Jana Friedrich, Kristin Dawczynski, Silke Furchtbar, Bernd Gruhn, Susann Wittig, Felix Zintl & Axel Sauerbrey. (2005) Are MTT assays the right tool to analyze drug resistance caused by ABC-transporters in patient samples?. Leukemia & Lymphoma 46:9, pages 1357-1363.
Read now

Articles from other publishers (4)

Barbara Nasilowska-Adamska, Iwona Solarska, Monika Paluszewska, Iwona Malinowska, Wieslaw W. Jedrzejczak & Krzysztof Warzocha. (2013) FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia. Annals of Hematology 93:4, pages 577-593.
Crossref
Jonathan E. KolitzStephen L. GeorgeGuido MarcucciRavi VijBayard L. PowellSteven L. AllenDaniel J. DeAngeloThomas C. SheaWendy StockMaria R. Baer, Vera HarsKati MaharryEva HokeJames W. VardimanClara D. BloomfieldRichard A. Larson. (2010) P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808. Blood 116:9, pages 1413-1421.
Crossref
Wojciech Gorczyca & Foxwell Nathan Emmons. 2008. Atlas of Differential Diagnosis in Neoplastic Hematopathology. Atlas of Differential Diagnosis in Neoplastic Hematopathology 542 566 .
Marry M. van den Heuvel-Eibrink, Bronno van der Holt, Alan K. Burnett, Wolfgang U. Knauf, Martin F. Fey, Gregor E. G. Verhoef, Edo Vellenga, Gert J. Ossenkoppele, Bob Löwenberg & Pieter Sonneveld. (2007) CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age. Annals of Hematology 86:5, pages 329-337.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.